Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.1126/scitranslmed.abo5795 | A persistent neutrophil-associated immune signature characterizes post–COVID-19 pulmonary sequelae |
| https://doi.org/10.1186/s13148-017-0351-5 | Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer |
| https://doi.org/10.2217/epi-2020-0186 | EZH2 Inhibition: A Promising Strategy to Prevent Cancer Immune Editing |
| https://doi.org/10.3390/cancers14143394 | Liquid Biopsy in Glioblastoma |
| https://doi.org/10.3389/fmolb.2021.600881 | Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression |
| https://doi.org/10.1038/s41598-021-88866-5 | Serial profiling of cell-free DNA and nucleosome histone modifications in cell cultures |
| https://doi.org/10.3390/biom12081038 | NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study |
| https://doi.org/10.1186/s12917-022-03429-8 | Evaluation of plasma nucleosome concentrations in dogs with a variety of common cancers and in healthy dogs |
| https://doi.org/10.1038/s41598-023-43520-0 | Epigenetic profiles of elevated cell free circulating H3.1 nucleosomes as potential biomarkers for non-Hodgkin lymphoma |
| https://doi.org/10.1038/s41598-021-86630-3 | A novel proteomics approach to epigenetic profiling of circulating nucleosomes |
| Novel serum nucleosomics biomarkers for the detection of colorectal cancer. | |
| https://doi.org/10.18632/oncotarget.21908 | Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer |
| https://doi.org/10.1186/s13148-017-0383-x | Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis |
| https://doi.org/10.1016/j.jbc.2025.110352 | High-throughput epigenetic profiling immunoassays for accelerated disease research and clinical development |
| https://doi.org/10.1371/journal.pone.0329352 | Quantification of H3.1-nucleosomes using a chemiluminescent immunoassay: A reliable method for neutrophil extracellular trap detection |
| https://doi.org/10.1055/s-0040-1722225 | NETosis Markers in Pregnancy: Effects Differ According to Histone Subtypes |
| https://doi.org/10.1080/00365521.2017.1299212 | Serological biomarkers in triage of FIT-positive subjects? |
| https://doi.org/10.1371/journal.pone.0236228 | Evaluation of nucleosome concentrations in healthy dogs and dogs with cancer |
| https://doi.org/10.1186/s12917-021-02934-6 | Characterizing circulating nucleosomes in the plasma of dogs with hemangiosarcoma |
| https://doi.org/10.1186/s13148-020-00969-4 | Circulating cell-free nucleosomes as biomarker for kidney transplant rejection: a pilot study |
| https://doi.org/10.2217/epi-2021-0383 | Predictive Significance of Circulating Histones in Hepatocellular Carcinoma Patients Treated with Sorafenib |
| https://doi.org/10.1080/00365513.2016.1190862 | Pre-analytical variables of circulating cell-free nucleosomes containing 5-methylcytosine DNA or histone modification H3K9Me3 |
| https://doi.org/10.3390/biom13081255 | Circulating H3K27 Methylated Nucleosome Plasma Concentration: Synergistic Information with Circulating Tumor DNA Molecular Profiling |
| https://doi.org/10.1096/fba.2024-00114 | |
| https://doi.org/10.1186/s13148-020-00915-4 | A new nucleosomic-based model to identify and diagnose SSc-ILD |
| https://doi.org/10.1200/jco.2020.38.15_suppl.e20078 | Circulating nucleosomes in hematological malignancy. |
| https://doi.org/10.1371/journal.pone.0281796 | Monitoring plasma nucleosome concentrations to measure disease response and progression in dogs with hematopoietic malignancies |
| https://doi.org/10.3390/cancers17060916 | Accurate Diagnosis of High-Risk Pulmonary Nodules Using a Non-Invasive Epigenetic Biomarker Test |
| https://doi.org/10.1093/annonc/mdx262.021 | Validation of Nu.Q™ colorectal cancer screening triage test to identify FIT positive individuals at low risk of screen relevant neoplasia |
| https://doi.org/10.3389/fcvm.2022.839720 | Differential Biological Effects of Dietary Lipids and Irradiation on the Aorta, Aortic Valve, and the Mitral Valve |
| https://doi.org/10.1200/jco.2022.40.16_suppl.e20558 | Circulating nucleosomes to identify non-smoker subjects at risk of lung cancer and triage them for low-dose CT scan. |
| https://doi.org/10.1093/annonc/mdw435.15 | A novel epigenetic immunoassay approach to profiling circulating nucleosomes for CRC detection |
| https://doi.org/10.1183/1393003.congress-2017.pa3864 | Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis |
| https://doi.org/10.1158/1538-7445.am2024-5128 | Abstract 5128: Circulating H3K27me3 modified nucleosomes as a biomarker to monitor anti EZH2-based treatment in advanced solid tumour patients: Translational analyses from CAIRE trial |
| https://doi.org/10.1101/2020.07.08.193466 | Evaluation of nucleosome concentrations in healthy dogs and dogs with cancer |
| https://doi.org/10.1101/401174 | The context-dependent nature of the neural implementation of intentions |
| https://doi.org/10.21203/rs.3.rs-310756/v1 | Characterizing Circulating Nucleosomes in the Plasma of Dogs with Hemangiosarcoma |
| https://doi.org/10.1101/2024.12.05.626944 | High-Throughput Epigenetic Profiling Immunoassays for Accelerated Disease Research and Clinical Development |
| https://doi.org/10.21203/rs.3.rs-1193590/v1 | Evaluation of Plasma Nucleosome Concentrations In Healthy Dogs And Dogs With A Variety of Common Cancers. |
| https://doi.org/10.1101/2023.02.02.526779 | Monitoring plasma nucleosome concentrations to measure disease response and progression in dogs with hematopoietic malignancies |
| https://doi.org/10.1101/2023.06.02.23290872 | Circulating H3K27 Methylated Nucleosome plasma concentration: a synergistic information with ctDNA Molecular Profiling |
| https://doi.org/10.1101/2024.05.02.592182 | Long-read sequencing identifies aberrant fragmentation patterns linked to elevated cell-free DNA levels in cancer |
| https://doi.org/10.1101/2024.09.06.611612 | EZH2 inhibition enhances the activity of platinum chemotherapy in aggressive-variant prostate cancer |
| https://doi.org/10.2217/bmm.14.47 | Development of NuQ ® Nucleosome Blood Tests for the Detection of Colon Cancer |
| https://doi.org/10.2217/crc.14.19 | Interview with VolitionRX on their nucleosomics blood tests for the detection of colorectal cancer |
| https://doi.org/10.2217/whe.15.17 | VolitionRx Begins First Ovarian Cancer Detection Study |
| Establishing a Logistics Command Centre - A journey describing the multi-disciplinary nature of IE projects | |
| https://doi.org/10.1158/1538-7445.am2016-4476 | Abstract 4476: Epigenetically altered circulating nucleosomes as blood biomarkers for early detection of cancer: clinical studies in NSCLC, CRC, PCA and PC |
| https://doi.org/10.1007/978-3-319-42044-8_36 | Academia Meets Industry |
| https://doi.org/10.1158/1538-7445.crc16-b02 | Abstract B02: Blood-based epigenetic profiling of circulating cell free nucleosomes in 2000 FIT positive individuals: A novel approach to colorectal cancer detection |
| https://doi.org/10.1200/jco.2020.38.15_suppl.e13534 | Enrichment of circulating tumor DNA from cell-free DNA of hematopoietic origin. |
| https://doi.org/10.1200/jco.2020.38.15_suppl.e15542 | Performance of a Nu.Q H3.1 assay for lung cancer detection. |
| https://doi.org/10.1183/13993003.congress-2020.798 | Levels of IGFBP-1, MMP-9 and circulating nucleosomes: a new model to diagnose SSc-ILD |
| https://doi.org/10.1016/j.jtho.2021.01.120 | FP09.03 Circulating Nucleosomes in Lung Cancer Diagnosis Following Low-Dose Computed Tomography |
| https://doi.org/10.1200/jco.2022.40.4_suppl.169 | Circulating nucleosomes for detection of colorectal cancer and high-risk advanced adenomas. |
| https://doi.org/10.1200/jco.2022.40.4_suppl.170 | Association of circulating nucleosomes levels with FIT performance for advanced adenomas in a symptomatic population. |
| https://doi.org/10.1200/jco.2022.40.16_suppl.e20533 | High specificity lung cancer test to rule out cancer in non-malignant lung nodules found at LDCT. |
| https://doi.org/10.1200/jco.2023.41.16_suppl.e15032 | Epigenetic profile of elevated cell free circulating nucleosomes in non-Hodgkin lymphoma. |
| https://doi.org/10.1093/noajnl/vdad070.072 | SDPS-13 CELL LINE STUDY OF NUCLEOSOME-BASED BIOMARKERS IN THE DIAGNOSIS AND DETECTION OF RELAPSES IN GLIOBLASTOMA |
| https://doi.org/10.1016/j.annonc.2023.09.2928 | 205P A novel immunoprecipitation/PCR method for detection of plasma cfDNA fragments selectively occupied by CTCF in cancer |
| https://doi.org/10.1016/j.annonc.2023.09.2858 | 133MO Differentiation of malignant and benign lung nodules using epigenetically modified nucleosomes in plasma |
| https://doi.org/10.1016/j.annonc.2023.09.1718 | 524P Cell line study of nucleosome-based biomarkers in the diagnosis and detection of relapses in glioblastoma |
| https://doi.org/10.1093/neuonc/noad179.0041 | BIOM-30. CELL LINE STUDY OF NUCLEOSOME-BASED BIOMARKERS IN THE DIAGNOSIS AND DETECTION OF RELAPSES IN GLIOBLASTOMA |
| https://doi.org/10.1016/j.esmoop.2024.102753 | 179P Immunoprecipitation of tumor-associated ctDNA fragments for novel lung cancer liquid biopsy |
| https://doi.org/10.1101/2024.12.05.24318548 | Accurate diagnosis of high-risk pulmonary nodules using a non-invasive epigenetic biomarker test |
| https://doi.org/10.1101/2025.03.05.641629 | Quantification of H3.1-nucleosomes using a chemiluminescent immunoassay: a reliable method for neutrophil extracellular trap detection |
| https://doi.org/10.1101/2025.03.14.25323908 | Early Cancer Detection in Asymptomatic Subjects through Measurement of Crosslinked cf-Nucleosomes in Plasma |
| https://doi.org/10.1016/s1556-0864(25)00587-8 | 395P: H3K27Me3-nucleosome is a strong prognostic biomarker in non-small cell lung cancer (NSCLC): Interim results from the analysis of up to 1050 samples at baseline |
| https://doi.org/10.1186/s12917-025-04785-x | Evaluation of plasma nucleosome concentrations and the effect of pre-analytical variables in healthy cats |
| https://doi.org/10.1016/j.annonc.2025.08.718 | 290eTiP Epigenetic nucleosomes in plasma for pulmonary nodule differentiation |
| https://doi.org/10.1093/neuonc/noaf201.0114 | BIOM-26. EPIGENETIC PROFILING OF PATIENT-DERIVED GLIOBLASTOMA CELLS USING NU.Q® IMMUNOASSAYS REVEALS A DISTINCT HISTONE MODIFICATION SIGNATURE |
| https://doi.org/10.21203/rs.3.rs-8047483/v1 | Direct analysis of transcription factor protected cfDNA in plasma by ChIP-seq: Measurement of altered CTCF binding in cancer is a novel biomarker for liquid biopsy |
| Cell line study of nucleosome-based biomarkers in the diagnosis and detection of relapses in glioblastoma | |
| Evaluation of Sivelestat as a NETosis inhibitor using an in-house ex-vivo model | |
| https://doi.org/10.1016/j.esmoop.2026.106552 | 244P Preoperative nucleosome liquid biopsy for prognostic stratification in lung cancer with treatment correlation |
| https://doi.org/10.21203/rs.3.rs-8047483/v2 | Direct analysis of transcription factor protected cfDNA in plasma by ChIP-seq: Measurement of altered CTCF binding in cancer is a novel biomarker for liquid biopsy |